Terumo (OTCMKTS:TRUMY) Shares Climb 9.4% – Still a Buy?

Terumo Corp. (OTCMKTS:TRUMY) shares shot up 9.4% during trading on Thursday. The stock traded as high as $16.4950 and last traded at $16.4622. 3,217 shares traded hands during trading, a decline of 99% from the average daily volume of 238,558 shares. The stock had previously closed at $15.05.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on TRUMY shares. Nomura upgraded Terumo from a “hold” rating to a “strong-buy” rating in a report on Thursday, July 30th. Zacks Research raised shares of Terumo from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, October 13th. Two research analysts have rated the stock with a Strong Buy rating. Based on data from MarketBeat.com, the company has an average rating of “Strong Buy”.

Terumo Trading Up 9.6%

The company has a 50 day moving average of $14.82 and a 200-day moving average of $14.02. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.37 and a current ratio of 2.19. The stock has a market cap of $24.35 billion, a price-to-earnings ratio of 23.25 and a beta of 0.82.

Terumo (OTCMKTS:TRUMY) last released its earnings results on Friday, August 7th. The company reported $0.30 earnings per share for the quarter, beating the consensus estimate of $0.17 by $0.13. The company had revenue of $1.97 billion during the quarter, compared to the consensus estimate of $1.84 billion. Terumo had a return on equity of 10.44% and a net margin of 13.83%. On average, research analysts anticipate that Terumo Corp. will post 0.86 earnings per share for the current year.

Terumo Company Profile

Terumo Corporation is a Japan-based medical technology company that develops, manufactures and sells medical devices and healthcare products. Its offerings support hospitals, physicians and other healthcare providers across areas including cardiovascular care, interventional procedures, blood management, cell and gene therapies, and general medical care.

The company’s products include catheters, guidewires, stents and other devices used in cardiovascular and endovascular procedures, as well as blood bags, apheresis systems, cell-processing technologies, infusion and injection products, and hospital equipment.